Overtreatment of COPD with inhaled corticosteroids--implications for safety and costs: cross-sectional observational study.

<h4>Introduction</h4>Combined inhaled long-acting beta-agonists and corticosteroids (LABA+ICS) are costly. They are recommended in severe or very severe chronic obstructive pulmonary disease (COPD). They should not be prescribed in mild or moderate disease. In COPD ICS are associated with side-effec...

全面介紹

書目詳細資料

Principais autores:	Patrick White, Hannah Thornton, Hilary Pinnock, Sofia Georgopoulou, Helen P Booth
格式:	Artigo
語言:	Inglês
出版:	Public Library of Science (PLoS) 2013-01-01
叢編:	PLoS ONE
在線閱讀:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0075221&type=printable
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!